Role of potassium in regulating blood flow and blood pressure.
Unlike sodium, potassium is vasoactive; for example, when infused into the arterial supply of a vascular bed, blood flow increases. The vasodilation results from hyperpolarization of the vascular smooth muscle cell subsequent to potassium stimulation by the ion of the electrogenic Na+-K+ pump and/or activating the inwardly rectifying Kir channels. In the case of skeletal muscle and brain, the increased flow sustains the augmented metabolic needs of the tissues. Potassium ions are also released by the endothelial cells in response to neurohumoral mediators and physical forces (such as shear stress) and contribute to the endothelium-dependent relaxations, being a component of endothelium-derived hyperpolarization factor-mediated responses. Dietary supplementation of potassium can lower blood pressure in normal and some hypertensive patients. Again, in contrast to NaCl restriction, the response to potassium supplementation is slow to appear, taking approximately 4 wk. Such supplementation reduces the need for antihypertensive medication. "Salt-sensitive" hypertension responds particularly well, perhaps, in part, because supplementation with potassium increases the urinary excretion of sodium chloride. Potassium supplementation may even reduce organ system complications (e.g., stroke).
Department of Physiology and Biomedical Engineering, Mayo Clinic, College of Medicine, Rochester, Minnesota, USA.
Francis J
FJ
Haddy
Paul M
PM
Vanhoutte
Michel
M
Feletou
D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D005246:Feedback / Q000502:physiology; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D011188:Potassium / Q000008:administration & dosage / Q000378:metabolism*; D015221:Potassium Channels / Q000378:metabolism*; D017419:Potassium, Dietary / Q000378:metabolism*; D017673:Sodium Chloride, Dietary / Q000009:adverse effects / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*
D015221:Potassium Channels; D017419:Potassium, Dietary; D017673:Sodium Chloride, Dietary; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium